Welcome to the 2020 Exhibitor Hub!
Virtual Exhibit Hall
$10,000 Corporate Members
Merck
www.merck.com Representative Mark Montello mark.montello@merck.com 603-321-1145 Click here to enter the Merck Zoom Room. |
Janssen Oncology
www.janssen.com/oncology Representative Peter Orrok porrok1@its.jnj.com 267-733-3020 Click here to learn more about our products. Watch Now: Janssen 2019 U.S. Transparency Report: 3 Things to Know Click here to enter the Janssen Oncology Zoom Room. |
Immunomedics
www.immunomedics.com Representatives Stephen Gardner, Oncology Account Manager sgardner@immunomedics.com Jim McDermott jmcdermott@immunomedics.com Click here to enter the Immunomedics Zoom Room. Passcode: 493945 |
$5,000 Corporate Members
Sanofi Genzyme
www.sarclisaHCP.com www.sanofigenzymeoncology-ourproducts.com Representatives Michael McDonald michael.mcdonald@sanofi.com 215-205-9773 Joe Strzelecki joseph.strzelecki@sanofi.com 215-570-4898 Amy Wascura amy.wascura@sanofi.com Nanette Rutherford nanette.rutherford@sanofi.com |
Pfizer Oncology
www.pfizer.com/oncology www.pfizeroncologycongressresources.com/OBU Representative Susan Sproat, Field Reimbursement Manager susan.r.sproat@pfizer.com |
Astellas
www.astellas.com Representatives Eric Tucker eric.tucker@astellas.com Mark Deleo mark.deleo@astellas.com Kristen Sichler kristen.sichler@astellas.com |
Seattle Genetics
www.seattlegenetics.com Representatives Jim Turconi jturconi@seagen.com Alyssa Levensten alevensten@seagen.com Kathy Cruz kcruz@seagen.com TUKYSA (tucatinib) tablets Prescribing Information. ADCETRIS (brentuximab vedotin) for injection Prescribing Information, including BOXED WARNING |
Gold Exhibitor
Deciphera
www.deciphera.com Representatives Cara Hlushak, Oncology Territory Manager, Philadelphia chlushak@deciphera.com John Rensel jrensel@deciphera.com QINLOCK™ (ripretinib) Management Brochure QINLOCK™ (ripretinib) Product Fact Sheet |
Silver Exhibitors
Incyte Corporation
www.incyte.com Representatives Wendy Keim, Oncology Therapeutic Specialist wkeim@incyte.com 570-492-0621 Phillip Holloway, Oncology Account Specialist pholloway@incyte.com 215-740-8816 Dave Moore, Oncology Therapeutic Specialist damoore@incyte.com 757-513-7730 Lisa McLain, Oncology Account Specialist lmclain@incyte.com 412-310-7030 Mitch Mensh mmensh@incyte.com Monjuvi (tafasitamab-cxix) information Pemazyre Full Prescribing Information Pemazyre now approved Jakafi Information Jakafi Prescribing Information Insurance and Financial Assistance for Eligible Patients Prescribed Jakafi (ruxolitinib) |
BeiGene
www.beigene.com www.brukinsa.com/hcp Representatives Carl Majeski, Account Manager Hematology carl.majeski@beigene.com Keli Frentzos, Account Manager Hematology keli.frentzos@beigene.com Darren Sand, Account Manager Hematology darren.sand@beigene.com Alicia Wasdworth, Account Manager Hematology alicia.wadsworth@beigene.com BeiGene is also hosting a non-CME Product Showcase titled "Discussion of Brukinsa™ For Adult Patients With Mantle Cell Lymphoma (MCL) Who Have Received At Least One Prior Therapy" at 11:45 AM on September 25. Learn more about the product showcase and enter the presentation here. |
Tempus
www.tempus.com Representatives Debi Wanamaker debi.wanamaker@tempus.com Jeff McKone jeff.mckone@tempus.com |
Pharmacyclics
www.imbruvicahcp.com Representative Cara Reinard creinard@pcyc.com IMBRUVICA Information IMBRUVICA Prescribing Information Clinical Information 1 Clinical Information 2 Clinical Information 3 IMBRUVICA Patient Support |
Lilly
www.syneoshealth.com Representatives Sarah Blasser sarah.blasser@syneoshealth.com 717-578-6159 Jason Wiener jason.wiener@syneoshealth.com 215-873-4925 For more information regarding Lilly products, please call The Lilly Answers Center at 1-800-LillyRx (1-800-545-5979) or email the_lillyanswerscenter@lilly.com. To request a Lilly sales representative visit https://www.lilly.com/resources/lilly-answers-center |